Cantitate/Preț
Produs

Cancer-Related Fatigue

Autor Joachim Weis, Markus Horneber
en Limba Engleză Paperback – 26 noi 2014
Cancer-related fatigue (CrF) is increasingly recognized as a significant problem for patients with cancer at all stages, including those undergoing therapy and in remission. In fact, studies have shown that CrF causes patients more distress than pain, nausea, or vomiting and yet fatigue is still often undertreated and rarely studied. However, several new treatments such as are being investigated to determine the most effective ways to manage this debilitating symptom and improve patient quality of life. Cancer-Related Fatigue will provide a concise overview of this condition, with an evidence-based discussion of diagnosis, treatment, and long-term management.
Citește tot Restrânge

Preț: 35465 lei

Preț vechi: 37332 lei
-5% Nou

Puncte Express: 532

Preț estimativ în valută:
6788 6995$ 5731£

Carte tipărită la comandă

Livrare economică 03-17 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781907673757
ISBN-10: 190767375X
Pagini: 74
Ilustrații: VII, 74 p. 7 illus., 2 illus. in color.
Dimensiuni: 127 x 190 x 12 mm
Greutate: 0.07 kg
Ediția:2015
Editura: Springer
Colecția Springer Healthcare
Locul publicării:Tarporley, United Kingdom

Public țintă

Professional/practitioner

Cuprins

Introduction.- Etiology and pathogenetic factors.- Nonpharmacological treatment of cancer-related fatigue.- Pharmacological treatment of cancer-related fatigue.- Recommendations for the management of cancer-related fatigue.

Notă biografică

Dr Markus Horneber, Department of Oncology/Hematology, Klinikum Nuernberg, Germany.
Dr Joachim Weis, Tumor Biology Centre, University of Freiburg, Germany.

Caracteristici

An ideal resource for general practitioners, oncologists, nursing specialists, and medical trainees interested in supportive care in oncology
Includes specifically targeted, clinically-relevant information with aim to positively impact patient care
An up-to-date, evidence-based discussion of recent drug developments in the cancer supportive care field